Form 4: Journey Medical COO Ramsey Alloush Receives Equity Grant

Journey Medical Corporation Chief Operating Officer Ramsey Alloush was granted 46,863 restricted stock units and 62,795 stock options.

Summary

• Ramsey Alloush, Chief Operating Officer of Journey Medical Corporation, received an equity compensation grant on April 22, 2026.
• The grant consists of 46,863 restricted stock units (RSUs) and 62,795 stock options.
• The stock options have an exercise price of $5.04 per share.
• Both the RSUs and stock options vest in three equal annual installments starting April 22, 2027, through April 22, 2029.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.

Positives

• Equity grants align the interests of the Chief Operating Officer with those of shareholders.
• The multi-year vesting schedule encourages long-term retention of key executive talent.

Negatives

• The issuance of new equity results in potential dilution for existing shareholders.

Risks

• Future share price volatility could impact the value of the granted options.
• The company remains subject to market risks inherent in the pharmaceutical industry.

Future Outlook

The filing does not provide specific forward-looking financial guidance, focusing instead on executive compensation structure.

Industry Context

StockSavvy.ai notes that equity-based compensation is a standard practice in the biotechnology and pharmaceutical sectors to incentivize executive performance and ensure long-term alignment with corporate growth objectives.

Comparison to Industry Standards

• The use of a three-year vesting schedule is consistent with standard corporate governance practices for executive compensation in the U.S. small-cap pharmaceutical industry.

Stakeholder Impact

• Shareholders may experience minor dilution from the issuance of new shares upon vesting.

Next Steps

• Vesting of the first tranche of equity on April 22, 2027.

Key Dates

Keywords

Journey Medical, DERM, Form 4, Insider Trading, Equity Compensation, Ramsey Alloush